BRUSSELS (Reuters) - The European Commission said on Wednesday that delivery shortfalls of AstraZeneca's COVID-19 vaccine were a global issue, not something to be addressed only in talks between the EU and Australia.
The comment followed Australia's request to the EU to send AstraZeneca doses. Canberra has said the EU has blocked shipments, whereas the EU says AstraZeneca had not requested new authorisations for exports to Australia.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!